| 000 | 01708 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517123243.0 | ||
| 264 | 0 | _c20171004 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1099-1557 | ||
| 024 | 7 |
_a10.1002/pds.4123 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBénard-Laribière, Anne | |
| 245 | 0 | 0 |
_aTrends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based study. _h[electronic resource] |
| 260 |
_bPharmacoepidemiology and drug safety _c02 2017 |
||
| 300 |
_a162-169 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Anxiety Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aAzabicyclo Compounds _xtherapeutic use |
| 650 | 0 | 4 |
_aBenzodiazepines _xpharmacokinetics |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aDrug Utilization _xtrends |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypnotics and Sedatives _xpharmacokinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 |
_aPyridines _xtherapeutic use |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 | _aZolpidem |
| 700 | 1 | _aNoize, Pernelle | |
| 700 | 1 | _aPambrun, Elodie | |
| 700 | 1 | _aBazin, Fabienne | |
| 700 | 1 | _aVerdoux, Hélène | |
| 700 | 1 | _aTournier, Marie | |
| 700 | 1 | _aBégaud, Bernard | |
| 700 | 1 | _aPariente, Antoine | |
| 773 | 0 |
_tPharmacoepidemiology and drug safety _gvol. 26 _gno. 2 _gp. 162-169 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/pds.4123 _zAvailable from publisher's website |
| 999 |
_c26572602 _d26572602 |
||